Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis

OBJECTIVE: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are the current standard of care for advanced or metastatic non-small cell lung cancer (NSCLC) patients harboring EGFR activating mutations. However, the optimal strategy for elderly NSCLC patients is still under de...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ziyi, Liu, Chengcheng, Zhu, Yixiang, Zou, Zihua, Xie, Tongji, Xing, Puyuan, Wang, Le, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077975/
https://www.ncbi.nlm.nih.gov/pubmed/35525919
http://dx.doi.org/10.1186/s12885-022-09592-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077975/
https://www.ncbi.nlm.nih.gov/pubmed/35525919
http://dx.doi.org/10.1186/s12885-022-09592-3

Ejemplares similares